UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of February 2018

 

Commission File Number 001-33042

 

ROSETTA GENOMICS LTD.

(Translation of registrant’s name into English)

 

10 Plaut Street, Science Park

Rehovot 76706, Israel

(Address of Principal Executive Offices) 

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-For Form 40-F:

Form 20-F x

Form 40-F ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):         ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):         ¨

                                   

  

  

Rosetta Genomics Ltd.

 

On February 16, 2018, Rosetta Genomics Ltd. (the “Company”) issued a press release urging shareholders to vote in favor of the proposed merger with Genoptix, Inc., and providing detail of the voting to-date. A copy of the press release is filed as Exhibit 99.1 to this Form 6-K and incorporated by reference herein.

 

 

Exhibits

 

Exhibit Number		Description of Exhibit
99.1		Press Release dated February 16, 2018.

  

  

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

	ROSETTA GENOMICS LTD.
Date: February 16, 2018	By:	/s/ Ron Kalfus
		Ron Kalfus
		Chief Financial Officer